# Vancomycin Dosage Adjustment for MRSA Infections

> **NCT03412500** · PHASE4 · UNKNOWN · sponsor: **Pinyo Rattanaumpawan** · enrollment: 114 (estimated)

## Conditions studied

- Methicillin-Resistant Staphylococcus Aureus

## Interventions

- **DRUG:** Vancomycin equation-based method
- **DRUG:** Vancomycin trough concentration method

## Key facts

- **NCT ID:** NCT03412500
- **Lead sponsor:** Pinyo Rattanaumpawan
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-10
- **Primary completion:** 2018-09
- **Final completion:** 2018-09
- **Target enrollment:** 114 (ESTIMATED)
- **Last updated:** 2018-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03412500

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03412500, "Vancomycin Dosage Adjustment for MRSA Infections". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT03412500. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*